|
CA1293460C
(en)
|
1985-10-07 |
1991-12-24 |
Brian Lee Sauer |
Site-specific recombination of dna in yeast
|
|
US4892824A
(en)
|
1988-03-15 |
1990-01-09 |
Synbiotics Corporation |
Fast track method for producing monoclonal bi-specific immunoglobulins
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
GB8904009D0
(en)
|
1989-02-22 |
1989-04-05 |
Celltech Ltd |
Vector
|
|
US6689610B1
(en)
|
1989-08-22 |
2004-02-10 |
University Of Utah Research Foundation |
Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
|
|
US5464764A
(en)
|
1989-08-22 |
1995-11-07 |
University Of Utah Research Foundation |
Positive-negative selection methods and vectors
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ATE352612T1
(de)
|
1990-08-29 |
2007-02-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
WO1992015694A1
(en)
|
1991-03-08 |
1992-09-17 |
The Salk Institute For Biological Studies |
Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
|
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
|
DE4228162C1
(de)
|
1992-08-25 |
1994-01-13 |
Rajewsky Klaus Dr |
Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
|
|
WO1994012215A1
(en)
*
|
1992-12-01 |
1994-06-09 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with l-selectin
|
|
CA2161351C
(en)
|
1993-04-26 |
2010-12-21 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US6084067A
(en)
|
1993-07-26 |
2000-07-04 |
Dana-Farber Cancer Institute |
CTLA4/CD28 ligands and uses therefor
|
|
US5593598A
(en)
|
1994-04-20 |
1997-01-14 |
Mcginness; Michael P. |
Method and apparatus for closed loop recycling of contaminated cleaning solution
|
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
DE19632532A1
(de)
|
1996-08-13 |
1998-02-19 |
Boehringer Ingelheim Int |
Verfahren zur Herstellung von Säugetieren mit definierten genetischen Eigenschaften
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
US6774279B2
(en)
|
1997-05-30 |
2004-08-10 |
Carnegie Institution Of Washington |
Use of FLP recombinase in mice
|
|
TWI255853B
(en)
|
1998-08-21 |
2006-06-01 |
Kirin Brewery |
Method for modifying chromosomes
|
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
|
DE60037896D1
(de)
|
1999-07-29 |
2008-03-13 |
Medarex Inc |
Menschliche antikörper gegen her2/neu
|
|
EA013564B1
(ru)
*
|
2000-08-03 |
2010-06-30 |
Терапеутик Хьюман Поликлоналз Инк. |
Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
|
|
FR2814642B1
(fr)
|
2000-10-03 |
2005-07-01 |
Ass Pour Le Dev De La Rech En |
Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20050144655A1
(en)
|
2000-10-31 |
2005-06-30 |
Economides Aris N. |
Methods of modifying eukaryotic cells
|
|
CN1487996B
(zh)
|
2000-11-30 |
2010-06-16 |
米德列斯公司 |
用于生产人类抗体的转基因转染色体啮齿动物
|
|
JP2004525627A
(ja)
|
2001-02-20 |
2004-08-26 |
ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド |
モノクローナル抗体の迅速な産生
|
|
US7476536B2
(en)
|
2001-05-11 |
2009-01-13 |
Kirin Pharma Kabushiki Kaisha |
Artificial human chromosome containing human antibody a light chain gene
|
|
US7473557B2
(en)
|
2001-06-06 |
2009-01-06 |
Regeneron Pharmaceuticals, Inc. |
Method for targeting transcriptionally active loci
|
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
|
US7323618B2
(en)
|
2002-02-01 |
2008-01-29 |
Origen Therapeutics, Inc. |
Tissue specific expression of exogenous proteins in transgenic chickens
|
|
US7145057B2
(en)
|
2002-02-01 |
2006-12-05 |
Origen Therapeutics, Inc. |
Chimeric bird from embryonic stem cells
|
|
GB2398784B
(en)
*
|
2003-02-26 |
2005-07-27 |
Babraham Inst |
Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
|
|
US7205148B2
(en)
|
2003-06-11 |
2007-04-17 |
Regeneron Pharmaceuticals, Inc. |
Genome mutation by intron insertion into an embryonic stem cell genome
|
|
DE10333239A1
(de)
|
2003-07-21 |
2005-03-10 |
Basf Ag |
Verfahren zur Herstellung von gereinigten 1,3- substituierten Imidazoliumsalzen
|
|
AU2005295269B2
(en)
|
2004-10-19 |
2010-05-13 |
Regeneron Pharmaceuticals, Inc. |
Method for generating an animal homozygous for a genetic modification
|
|
US7422889B2
(en)
|
2004-10-29 |
2008-09-09 |
Stowers Institute For Medical Research |
Dre recombinase and recombinase systems employing Dre recombinase
|
|
AU2007235496B2
(en)
|
2006-03-31 |
2013-11-21 |
E. R. Squibb & Sons, L.L.C. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
|
WO2008070367A2
(en)
|
2006-11-01 |
2008-06-12 |
Facet Biotech Corporation |
Mammalian cell-based immunoglobulin display libraries
|
|
GB0700194D0
(en)
|
2007-01-05 |
2007-02-14 |
Univ Edinburgh |
Humanisation of animals
|
|
DK2602323T3
(en)
|
2007-06-01 |
2018-04-16 |
Open Monoclonal Tech Inc |
Compositions and Methods for Inhibiting Endogenous Immunoglobin Genes and Producing Transgenic Human Idiotypic Antibodies
|
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
|
WO2009097006A2
(en)
|
2007-08-10 |
2009-08-06 |
Medarex, Inc. |
Hco32 and hco27 and related examples
|
|
US7947495B2
(en)
|
2007-11-01 |
2011-05-24 |
Abbott Biotherapeutics Corp. |
Immunoglobulin display vectors
|
|
PL3456190T3
(pl)
|
2008-06-27 |
2022-06-06 |
Merus N.V. |
Wytwarzające przeciwciała transgeniczne zwierzę z gatunku myszy
|
|
EP2346994B1
(en)
|
2008-09-30 |
2022-02-16 |
Ablexis, LLC |
Knock-in mice for the production of chimeric antibodies
|
|
US20100317539A1
(en)
|
2009-06-12 |
2010-12-16 |
Guo-Liang Yu |
Library of Engineered-Antibody Producing Cells
|
|
BR112012000536A2
(pt)
|
2009-07-08 |
2020-08-11 |
Kymab Limited |
métodos para produção de anticorpo ou cadeia leve ou pesada de anticorpo específico para um antígeno desejado, para produção de anticorpo ou cadeia de anticorpo e seu uso, composição farmacêutica e derivado de anticorpo quimérico
|
|
US8754287B2
(en)
|
2009-12-10 |
2014-06-17 |
Regeneron Pharmaceuticals, Inc. |
Mice that make heavy chain antibodies
|
|
KR102203727B1
(ko)
|
2010-03-31 |
2021-01-18 |
아블렉시스, 엘엘씨 |
키메라 항체의 제조를 위한 비-인간 동물의 유전적 조작
|
|
AU2011266843C9
(en)
|
2010-06-17 |
2018-03-01 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
US9012717B2
(en)
|
2010-06-22 |
2015-04-21 |
Regeneron Pharmaceuticals, Inc. |
Human lambda light chain mice
|
|
US10793829B2
(en)
|
2010-07-26 |
2020-10-06 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
|
US10662256B2
(en)
|
2010-07-26 |
2020-05-26 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
|
JP6482757B2
(ja)
*
|
2010-07-26 |
2019-03-13 |
トリアンニ インコーポレイテッドＴｒｉａｎｎｉ，Ｉｎｃ． |
トランスジェニック動物および使用方法
|
|
SG10201912639SA
(en)
|
2010-08-02 |
2020-02-27 |
Regeneron Pharma |
Mice that make binding proteins comprising vl domains
|
|
IN2013MN01438A
(https=)
|
2011-03-17 |
2015-06-12 |
Univ Ramot |
|
|
RS59728B1
(sr)
|
2011-08-05 |
2020-02-28 |
Regeneron Pharma |
Humanizovani miševi univerzalnog lakog lanca
|
|
US20140283153A1
(en)
|
2011-10-28 |
2014-09-18 |
Trianni, Inc. |
Transgenic animals and methods of use
|
|
GB2504139B
(en)
|
2012-07-20 |
2014-12-31 |
Argen X Bv |
Antibodies to highly conserved targets produced by the immunisation of Camelidae species
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
RU2664181C2
(ru)
|
2011-12-20 |
2018-08-15 |
Регенерон Фармасьютикалз, Инк. |
Мыши с гуманизированной легкой цепью
|
|
WO2013092720A1
(en)
|
2011-12-22 |
2013-06-27 |
F. Hoffmann-La Roche Ag |
Full length antibody display system for eukaryotic cells and its use
|
|
MX2014011047A
(es)
|
2012-03-16 |
2015-04-08 |
Regeneron Pharma |
Ratones que producen proteinas de union a un antigeno con caracteristicas de union dependientes del ph.
|
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
|
PT3597037T
(pt)
|
2012-06-12 |
2021-06-01 |
Regeneron Pharma |
Animais não humanos humanizados com lócus de cadeia pesada de imunoglobulina restrito
|
|
JPWO2014021240A1
(ja)
|
2012-08-03 |
2016-07-21 |
国立研究開発法人産業技術総合研究所 |
プロテインｇの細胞膜外ドメイン変異体のタンデム型多量体から成るタンパク質を含む捕捉剤
|
|
US10034463B2
(en)
|
2014-01-24 |
2018-07-31 |
Children's Medical Center Corporation |
High-throughput mouse model for optimizing antibody affinities
|
|
ES2928000T3
(es)
|
2014-06-06 |
2022-11-14 |
Memorial Sloan Kettering Cancer Center |
Receptores de antígeno quimérico dirigidos a mesotelina y usos de los mismos
|
|
US20170058052A1
(en)
|
2015-08-24 |
2017-03-02 |
Trianni, Inc. |
Enhanced production of immunoglobulins
|
|
EP3384030A4
(en)
|
2015-12-03 |
2019-07-03 |
Trianni, Inc. |
IMPROVED IMMUNOGLULINIVITY
|
|
AU2017213633B2
(en)
|
2016-02-04 |
2023-08-03 |
Trianni, Inc. |
Enhanced production of immunoglobulins
|
|
WO2018128691A1
(en)
|
2016-11-04 |
2018-07-12 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having an engineered immunoglobulin lambda light chain locus
|
|
GB2561352B
(en)
|
2017-04-10 |
2023-01-18 |
Genome Res Ltd |
Animal models and therapeutic molecules
|
|
DK4140297T3
(da)
|
2017-12-05 |
2025-06-23 |
Regeneron Pharma |
Mus med en konstrueret immunglobulin-lambda-letkæde og anvendelser deraf
|